http://www.acc.org/Feed?clinicalTopicID=4e7de144-8d5e-4458-886d-76ce2c5a0b66 Clinical Topic Feed: Interventions and Vascular Medicine en /Latest-in-Cardiology/Articles/2026/04/07/19/53/host-exam-acc-2026 Clopidogrel monotherapy after PCI was associated with a significantly lower composite risk of all-cause death, nonfatal MI, stroke, readmission for acute coronary syndrome (ACS) and major bleeding compared with aspirin monotherapy, according to 10-year follow-up results of the HOST-EXAM trial presented as featured clinical research at ACC.26 and published simultaneously in The Lancet. 1775593440000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-surviv-acc-2026 Among patients with a failed mitral bioprosthetic valve, transcatheter mitral valve-in-valve (mVIV) treatment was associated with a lower rate of death or disabling stroke at one year compared with standard repeat mitral valve replacement surgery (rMVR), according to results from the SURVIV study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774818000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sat-930am-stemidtu-acc-2026 Compared with immediate PCI alone, the combination of mechanical left ventricular (LV) unloading using a transvalvular micro-axial flow pump (TV-mAFP) plus delayed PCI did not reduce infarct size in patients with anterior STEMI without cardiogenic shock, according to findings from the STEMI-DTU trial presented at ACC.26 and simultaneously published in JACC. 1774708320000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/03/19/17/12/Dobermann Two brief reports in JACC on the DOBERMANN-T and DOBERMANN-D trials found that among patients with acute myocardial infarction (AMI) at increased risk of cardiogenic shock (CS), early interleukin 6 (IL 6) receptor inhibition with tocilizumab safely reduced systemic inflammation but showed inconclusive effects on NT proBNP. In contrast, early dobutamine infusion did not lower NT proBNP levels but did reduce systolic blood pressure (SBP) without raising safety concerns. 1773942840000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/16/16/27/Pre-Hospital-Glycoprotein-IIb-IIIa-Inhibition-With-Zalunfiban-in-STEMI The CELEBRATE (CeleCor Blinded Randomized Trial in ST-Elevation Myocardial Infarction) trial was a phase 3, multicenter, double-blind, placebo-controlled study that evaluated the efficacy and safety of a single subcutaneous injection of zalunfiban (CeleCor Therapeutics), a novel glycoprotein IIb/IIIa inhibitor... 1773751800000 Articles and Stories /Latest-in-Cardiology/Articles/2026/02/24/16/30/eagles-eye-view-24feb2025 In this week’s View, Dr. Eagle looks at findings from the Evolut Low Risk trial in which self-expanding transcatheter aortic valve replacement (TAVR) versus surgery at six years in low-risk patients with aortic stenosis (AS) is considered. 1772031600000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/02/17/14/32/ACC-AHA-Release-First-Ever-Guideline-For-Treatment-and-Management-of-Acute-PE The new ACC/AHA Guideline for the Evaluation and Management of Acute Pulmonary Embolism (PE) in Adults is a de novo document offering comprehensive, evidence‑based recommendations for the evaluation, management and follow‑up of adults with acute PE. 1771527600000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/02/11/18/58/Substantial-Hospital-Level-Variation-in-Immediate-Coronary-Angiography-Among-Patients-With-STEMI-and-OHCA-NCDR-Study Among patients presenting with both out-of-hospital cardiac arrest (OHCA) and STEMI, substantial hospital-level variation was found in providing immediate coronary angiography (CA), according to a Brief Report published Feb. 11 in JACC. 1770836700000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/01/22/18/26/REUP-For-DCD Rapid recovery with extended ultraoxygenated preservation (REUP) for donation after circulatory death (DCD) was found to be feasible regardless of donor age and ischemic time, according to a study published Jan. 26 in JAMA. 1769520060000 Articles and Stories /Latest-in-Cardiology/Articles/2026/01/01/01/From-the-Member-Sections-Closing-the-Gap Peripheral artery disease (PAD) affects the lives of an estimated 21 to 27 million Americans. It is a misconception that PAD comes in isolation; in fact, most patients (>60-70%) also have concomitant coronary artery disease and/or cerebrovascular disease. 1769001300000 Articles and Stories